• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-K filed by HWH International Inc.

    3/31/25 4:05:57 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care
    Get the next $HWH alert in real time by email

    Unavailable

    Get the next $HWH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HWH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HWH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HWH International Inc. Announces Reverse Stock Split

    BETHESDA, MD, Feb. 20, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the "Company") (NASDAQ:HWH), a purpose-driven lifestyle company, today announced a 1-for-5 reverse stock split of the Company's common stock to become effective at 9:00 a.m. (Eastern Time) on February 24, 2025. The Company's common stock is expected to begin trading on a split-adjusted basis when the markets open on February 24, 2025, under the existing trading symbol "HWH." The reverse stock split is primarily intended to bring the Company into compliance with the minimum bid price requirements for maintaining its listing on the Nasdaq Capital Market. The new CUSIP number following the reverse stock split will be 448

    2/20/25 8:50:00 AM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    D. Boral Capital Served as Placement Agent to HWH International Inc. (Nasdaq: HWH) in connection with its approximately $1.76 Million Public Offering

    BETHESDA, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the "Company") (NASDAQ:HWH), a purpose-driven lifestyle company, today announced the closing of its public offering (the "Offering") with aggregate gross proceeds to the Company of $1,764,900, prior to deducting fees and other expenses payable by the Company. The Offering consisted of 3,412,500 shares of common stock and 1,000,000 pre-funded warrants to purchase 1,000,000 shares of common stock. Each share of common stock (or pre-funded warrant in lieu thereof) was sold at a purchase price of $0.40 per share (or $0.3999 per pre-funded warrant after reducing $0.0001 attributable to the exercise price of the pre-funded

    1/7/25 11:18:56 AM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    HWH International Inc. Announces Closing of Approximately $1.76 Million Public Offering at $0.40 per Share

    BETHESDA, MD, Jan. 06, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the "Company") (NASDAQ:HWH), a purpose-driven lifestyle company, today announced the closing of its public offering (the "Offering") with aggregate gross proceeds to the Company of $1,764,875, prior to deducting fees and other expenses payable by the Company. The Offering consisted of 3,125,000 shares of common stock and 1,250,000 pre-funded warrants to purchase 1,250,000 shares of common stock. Each share of common stock (or pre-funded warrant in lieu thereof) was sold at a purchase price of $0.40 per share (or $0.3999 per pre-funded warrant after reducing $0.0001 attributable to the exercise price of the pre-funded w

    1/6/25 4:20:00 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    $HWH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Chan Heng Fai Ambrose bought $585,000 worth of shares (1,300,000 units at $0.45) (SEC Form 4)

    4 - HWH International Inc. (0001897245) (Issuer)

    12/26/24 5:15:05 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    Director Chan Heng Fai Ambrose bought $3,000,000 worth of shares (4,411,764 units at $0.68) (SEC Form 4)

    4 - HWH International Inc. (0001897245) (Issuer)

    11/26/24 7:12:12 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Chan Heng Fai Ambrose bought $3,801,758 worth of shares (6,034,537 units at $0.63) (SEC Form 4)

    4 - HWH International Inc. (0001897245) (Issuer)

    9/26/24 9:39:51 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    $HWH
    SEC Filings

    View All

    SEC Form PRE 14C filed by HWH International Inc.

    PRE 14C - HWH International Inc. (0001897245) (Filer)

    10/10/25 5:15:24 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    SEC Form DEF 14A filed by HWH International Inc.

    DEF 14A - HWH International Inc. (0001897245) (Filer)

    10/9/25 4:15:20 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    HWH International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - HWH International Inc. (0001897245) (Filer)

    10/8/25 5:18:08 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    $HWH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Large owner Chan Heng Fai Ambrose

    4 - HWH International Inc. (0001897245) (Reporting)

    10/7/25 5:00:04 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    SEC Form 4 filed by Large owner Chan Heng Fai Ambrose

    4 - HWH International Inc. (0001897245) (Reporting)

    9/19/25 4:15:26 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    SEC Form 4 filed by Executive Chairman Chan Heng Fai Ambrose

    4 - HWH International Inc. (0001897245) (Reporting)

    4/2/25 8:37:43 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    $HWH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by HWH International Inc.

    SC 13D/A - HWH International Inc. (0001897245) (Subject)

    11/26/24 7:34:11 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13D/A filed by HWH International Inc.

    SC 13D/A - HWH International Inc. (0001897245) (Subject)

    11/22/24 5:00:10 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13G/A filed by HWH International Inc.

    SC 13G/A - HWH International Inc. (0001897245) (Subject)

    11/14/24 12:40:52 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care

    $HWH
    Financials

    Live finance-specific insights

    View All

    HWH International Inc. Acquires Café in South Korea, Unveiling Second Hapi Cafe Outlet

    Bethesda, MD, Feb. 26, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. ("HWH") (NASDAQ:HWH) proudly announces the acquisition of a café in Seocho-gu, South Korea, marking the launch of its second Hapi Cafe outlet in South Korea. HWH is delighted to reveal its latest acquisition of a café nestled in the heart of Seocho-gu, South Korea. This strategic move signifies HWH's dedication to providing unique and welcoming spaces where people can gather to savor food, coffee, and experiences. These cafes are a significant driver of our Health, Wealth, and Happiness vision to offer delicious and nutritious food and beverages to our customers and provide a platform where we can roll out lifestyle pr

    2/26/24 4:15:00 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care